P3 Health Partners Inc. (NASDAQ:PIII) Short Interest Update

P3 Health Partners Inc. (NASDAQ:PIIIGet Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 957,100 shares, a decline of 23.4% from the October 15th total of 1,250,000 shares. Based on an average trading volume of 657,700 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.4% of the company’s shares are sold short.

P3 Health Partners Trading Up 9.1 %

Shares of PIII traded up $0.02 during trading hours on Friday, hitting $0.23. The company had a trading volume of 887,485 shares, compared to its average volume of 628,607. P3 Health Partners has a 52-week low of $0.20 and a 52-week high of $1.78. The company has a quick ratio of 0.69, a current ratio of 0.53 and a debt-to-equity ratio of 1.11. The stock’s 50 day moving average price is $0.40 and its 200 day moving average price is $0.51. The firm has a market cap of $81.74 million, a P/E ratio of -0.27 and a beta of 1.15.

Insider Transactions at P3 Health Partners

In other P3 Health Partners news, major shareholder Pacific Founders Ugp I. Chicago bought 80,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were bought at an average price of $0.49 per share, for a total transaction of $39,200.00. Following the transaction, the insider now directly owns 76,785,438 shares in the company, valued at $37,624,864.62. This trade represents a 0.10 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last ninety days, insiders acquired 400,000 shares of company stock worth $205,600. 17.86% of the stock is currently owned by insiders.

Institutional Trading of P3 Health Partners

Several hedge funds and other institutional investors have recently bought and sold shares of PIII. Armistice Capital LLC bought a new position in shares of P3 Health Partners in the second quarter worth approximately $3,557,000. Geode Capital Management LLC grew its holdings in P3 Health Partners by 115.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock worth $398,000 after acquiring an additional 550,925 shares during the last quarter. Emfo LLC increased its position in shares of P3 Health Partners by 39.8% in the second quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after acquiring an additional 406,418 shares during the period. Renaissance Technologies LLC raised its stake in shares of P3 Health Partners by 188.1% during the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock valued at $50,000 after acquiring an additional 73,000 shares during the last quarter. Finally, Sanders Morris Harris LLC raised its stake in shares of P3 Health Partners by 16.3% during the second quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock valued at $64,000 after acquiring an additional 20,000 shares during the last quarter. Institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

See Also

Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.